	Liquidités		Date
AbbVie	USD 5.63B	838M	2025-09
Acadia Pharmaceuticals	USD 847.02M	85.02M	2025-09
Akebia Therapeutics	USD 166.44M	29.14M	2025-09
ALKERMES	USD 616.45M	95.25M	2025-09
Alnylam Pharmaceuticals	USD 1.49B	376.56M	2025-09
Amarin	USD 122.8M	25.08M	2025-09
Amgen	USD 9.13B	316M	2025-12
Baxter International	USD 1.73B	40M	2025-09
Biogen	USD 3.01B	854.3M	2025-12
BioMarin Pharmaceutical	USD 1.25B	36.29M	2025-09
Bristol-Myers Squibb	USD 10.21B	5.52B	2025-12
Coherus Biosciences	USD 103.35M	113.54M	2025-09
Eli Lilly	USD 9.79B	6.42B	2025-09
Fujifilm	JPY 160.88B	906M	2025-09
Gilead Sciences	USD 7.33B	2.19B	2025-09
Ironwood Pharmaceuticals	USD 140.41M	47.56M	2025-09
Merck	USD 18.17B	10.16B	2025-09
Myriad Genetics	USD 145.4M	71M	2025-09
Pacira	USD 147.59M	152.89M	2025-09
Perrigo	USD 432.1M	22.1M	2025-09
Pfizer	USD 1.34B	295M	2025-09
PTC Therapeutics	USD 672.62M	344.77M	2025-09
Regeneron Pharmaceuticals	USD 18.87B	16.36B	2025-12
Sarepta Therapeutics	USD 613.08M	102.48M	2025-09
Teva Pharmaceutical Industries	USD 3.56B	1.35B	2025-12
Vertex Pharmaceuticals	USD 6.29B	95.8M	2025-09
Xencor	USD 28.29M	16.15M	2025-09
Zoetis	USD 2.08B	649M	2025-09

Coherus Biosciences Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.